A phase 1 trial of valemetostat in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) or acute lymphocytic leukemia (ALL) Meeting Abstract
| Authors: | Erba, H. P.; Oluwole, O. O.; Bixby, D.; Rampal, R. K.; Fathi, A. T.; Paliwal, P.; Jin, J.; Inoue, A.; Daver, N. |
| Abstract Title: | A phase 1 trial of valemetostat in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) or acute lymphocytic leukemia (ALL) |
| Meeting Title: | 12th Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) |
| Keywords: | phase 1; aml; all; ezh; valemetostat |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Sep 4-7 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S311 |
| End Page: | S312 |
| Language: | English |
| ACCESSION: | WOS:001315579603026 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)01195-9 |
| Notes: | Meeting Abstract: AML-385 -- Meeting was also available online -- Source: Wos |
